These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38988404)

  • 1. Decentralised ECG monitoring for drug-resistant TB patients in ambulatory settings.
    Mbenga M; Slyzkyi A; Mirtskhulava V; Pak S; Gebhard A; Utepkalieva G; Sagimbekova A; Adenov M; Ryskulov G
    IJTLD Open; 2024 Apr; 1(4):192-194. PubMed ID: 38988404
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost effectiveness of decentralised care model for managing MDR-TB in India.
    John D; Chatterjee P; Murthy S; Bhat R; Musa BM
    Indian J Tuberc; 2018 Jul; 65(3):208-217. PubMed ID: 29933862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-to-Treatment Initiation in a Decentralised Community-Care Model of Drug-Resistant Tuberculosis Management in the OR Tambo District Municipality of South Africa.
    Iruedo JO; Pather MK
    Int J Environ Res Public Health; 2023 Jul; 20(14):. PubMed ID: 37510655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa.
    Loveday M; Wallengren K; Voce A; Margot B; Reddy T; Master I; Brust J; Chaiyachati K; Padayatchi N
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):209-15. PubMed ID: 22236922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lived experiences of patients and families with decentralised drug-resistant tuberculosis care in the Eastern Cape, South Africa.
    Iruedo JO; Pather MK
    Afr J Prim Health Care Fam Med; 2023 Dec; 15(1):e1-e16. PubMed ID: 38197684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of reduced hospitalisation on the cost of treatment for drug-resistant tuberculosis in South Africa.
    Sinanovic E; Ramma L; Vassall A; Azevedo V; Wilkinson L; Ndjeka N; McCarthy K; Churchyard G; Cox H
    Int J Tuberc Lung Dis; 2015 Feb; 19(2):172-8. PubMed ID: 25574915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decentralised care for the management of child contacts of multidrug-resistant tuberculosis.
    Seddon JA; Hesseling AC; Dunbar R; Cox H; Hughes J; Fielding K; Godfrey-Faussett P; Schaaf HS
    Public Health Action; 2012 Sep; 2(3):66-70. PubMed ID: 26392954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Missed appointments among rifampicin-resistant tuberculosis (RR-TB) patients at a decentralised RR-TB outpatient clinic in Johannesburg, South Africa.
    Gajee R; Schnippel K; Mthupha N; Muzah B; Berhanu R
    S Afr Med J; 2016 Aug; 106(9):912-7. PubMed ID: 27601119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a novel single lead ambulatory ECG monitor - Cardiostat™ - Compared to a standard ECG Holter monitoring.
    Nault I; André P; Plourde B; Leclerc F; Sarrazin JF; Philippon F; O'Hara G; Molin F; Steinberg C; Roy K; Blier L; Champagne J
    J Electrocardiol; 2019; 53():57-63. PubMed ID: 30641305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms.
    Kohler S; Asadov DA; Bründer A; Healy S; Khamraev AK; Sergeeva N; Tinnemann P
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1390-5. PubMed ID: 25517802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quality of ECG data acquisition, and diagnostic performance of a novel adhesive patch for ambulatory cardiac rhythm monitoring in arrhythmia detection.
    Karaoğuz MR; Yurtseven E; Aslan G; Deliormanlı BG; Adıgüzel Ö; Gönen M; Li KM; Yılmaz EN
    J Electrocardiol; 2019; 54():28-35. PubMed ID: 30851474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of a Handheld 6-Lead Device for QT Interval Monitoring in Resource-Limited Settings.
    Metcalfe JZ; Economou T; Naufal F; Kucukosmanoglu M; Kleiman R; Phillips PPJ; Conradie F
    JAMA Netw Open; 2024 Jun; 7(6):e2415576. PubMed ID: 38848063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of three models of care for drug-resistant tuberculosis patients in Nigeria.
    Bada FO; Okpokoro E; Blok N; Meribole E; Dutt S; Dakum P; Abimiku A; Zwerling A; Kik SV
    BMC Infect Dis; 2019 Jan; 19(1):41. PubMed ID: 30630429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Continuous ECG Monitoring by Wearable Patch Device and Conventional Telemonitoring Device.
    Choi W; Kim SH; Lee W; Kang SH; Yoon CH; Youn TJ; Chae IH
    J Korean Med Sci; 2020 Nov; 35(44):e363. PubMed ID: 33200590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Provider perspectives of the introduction and implementation of care for drug-resistant tuberculosis patients in district-level facilities in South Africa: a qualitative study.
    Vanleeuw L; Atkins S; Zembe-Mkabile W; Loveday M
    BMJ Open; 2020 Feb; 10(2):e032591. PubMed ID: 32019816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decentralising tuberculosis services from county tuberculosis dispensaries to township hospitals in China: an intervention study.
    Wei X; Liang X; Liu F; Walley JD; Dong B
    Int J Tuberc Lung Dis; 2008 May; 12(5):538-47. PubMed ID: 18419890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time to commencement of effective treatment in patients with drug-resistant tuberculosis diagnosed in the Torres Strait-Papua New Guinea cross-border region.
    Foster J; Mendez D; Marais B; Peniyamina D; McBryde E
    Rural Remote Health; 2023 Mar; 23(1):7165. PubMed ID: 36977420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for paroxysmal atrial fibrillation in primary care using Holter monitoring and intermittent, ambulatory single-lead electrocardiography.
    Karregat EPM; Gurp NV; Bouwman AC; Uittenbogaart SB; Himmelreich JCL; Lucassen WAM; Krul SPJ; van Kesteren HAM; Luermans JGLM; van Weert HCPM; Stoffers HEJH
    Int J Cardiol; 2021 Dec; 345():41-46. PubMed ID: 34687805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of rifampicin-resistant TB: programme indicators and care cascade analysis in South Africa.
    De Vos E; Scott L; Voss De Lima Y; Warren RM; Stevens W; Hayes C; da Silva P; Van Rie A
    Int J Tuberc Lung Dis; 2021 Feb; 25(2):134-141. PubMed ID: 33656425
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful expansion of community-based drug-resistant TB care in rural Eswatini - a retrospective cohort study.
    Kerschberger B; Telnov A; Yano N; Cox H; Zabsonre I; Kabore SM; Vambe D; Ngwenya S; Rusch B; Tombo ML; Ciglenecki I
    Trop Med Int Health; 2019 Oct; 24(10):1243-1258. PubMed ID: 31390108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.